Matrix metalloproteinase-assisted triggered release of liposomal contents

Bioconjugate Chemistry

Volumn 19, Issue 1, 2008, Pages 57-64

  Sarkar, Nihar ^a   Banerjee, Jayati ^a   Hanson, Andrea J ^a   Elegbede, Adekunle I ^a   Rosendahl, Theresa ^a   Krueger, Aaron B ^a   Banerjee, Abir L ^a   Tobwala, Shakila ^a   Wang, Rongying ^b   Lu, Xiaoning ^b   Mallik, Sanku ^a   Srivastava, D K ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN; GELATINASE B; LIPOPEPTIDE; LIPOSOME; MATRIX METALLOPROTEINASE; PEPTIDE DERIVATIVE; TRYPSIN;

ARTICLE; CHRONOLOGY; DRUG RELEASE; ENZYME ACTIVITY; ENZYME SPECIFICITY; LIPOSOMAL DELIVERY; MICROENCAPSULATION; PROTEIN DEGRADATION;

EID: 38949203367     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc070081p     Document Type: Article

References (35)

1. Malemud, C. J. (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 11, 1696-1701.
2. Deryugina, E. I., and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34.
3. Verma, R. P., and Hansch, C. (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15, 2223-2268.
4. La Rocca, G., Pucci-Minafra, I., Marrazzo, A., Taormina, P., and Minafra, S. (2004) Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer 90, 1414-1421.
5. Mook, O. R. F., Frederiks, W. M., and Van Noorden, C. J. F. (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 1705, 69-89.
6. Osinsky, S. P., Ganusevich, I. I., Bubnovskaya, L. N., Valkovskaya, N. V., Kovelskaya, A. V., Sergienko, T. K., and Zimina, S. V. (2005) Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: Correlation with metastasis. Exp. Oncol. 27, 202-205.
7. Dong, Z., Bonfil, R. D., Chinni, S., Deng, X., Trindade Filho, J. C., Bernardo, M., Vaishampayan, U., Che, M., Sloane, B. F., Sheng, S., Fridman, R., and, and Cher, M. L. (2005) Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am. J. Pathol. 166, 1173-1186.
8. Keleg, S., Büchler, P., Ludwig, R., Büchler, M. W., and Friess, H. (2003) Invasion and metastasis in pancreatic cancer. Mol. Cancer 2, 14-20.
9. Roomi, M. W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., and Rath, M. (2006) Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SKOV-3 with lysine, proline, arginine, ascorbic acid and green tea extract. J. Obstet. Gynaecol. Res. 32, 148-157.
10. Fisher, J. F., and Mobashery, S. (2006) Recent advances in MMP inhibitor design. Cancer Metastasis Rev. 25, 115-136.
11. Cuenca, A. G., Jiang, H., Hochwald, S. N., Delano, M., Cance, W. G., and Grobmyer, S. R. (2006) Emerging implications of nanotechnology on cancer diagnosis and therapeutics. Cancer 107, 459-466.
12. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 4, 145-160.
13. Anderson, T. L., Jensen, S. S., and Jorgensen, K. (2005) Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog. Lipid Res. 44, 68-97.
14. Torchilin, V. P. (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Ann. Rev. Biomed. Eng. 8, 343-375.
15. Gabizon, A. A., Shmeeda, H., and Zalipsky, S. (2006) Pros and cons of the liposome platform in cancer drug targeting. J. Liposome Res. 16, 175-183.
16. Karanth, H., and Murthy, R. S. R. (2007) pH-sensitive liposomes-principle and application in cancer therapy. J. Pharm. Pharmacol. 59, 469-483.
17. Karoonuthaisiri, N., Titiyevskiy, K., and Thomas, J. L. (2003) Destabilization of fatty acid-containing liposomes by polyamidoamine dendrimers. Colloids Surf., B: Biointerfaces 27, 365-375.
18. Davis, S. C., and Szoka, F. C. (1998) Cholesterol phosphate derivatives: synthesis and incorporation into a phosphate and calcium sensitive triggered release liposome. Bioconjugate Chem. 9, 783-792.
19. Hauck, M. L., LaRue, S. M., Petros, W. P., Poulson, J. M., Yu, D., Spasojevic, I., Pruitt, A. F., Klein, A., Case, B., Thrall, D. E., Needham, D., and Dewhirst, M. W. (2006) Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin. Cancer Res. 12, 4004-4010.
20. Liu, X. M., Yang, B., Wang, Y. L., and Wang, J. Y. (2005) Photoisomerisable cholesterol derivatives as photo-trigger of liposomes: effect of lipid polarity, temperature, incorporation ratio, and cholesterol. Biochim. Biophys. Acta 1720, 28-34.
21. Andresen, T. L., Jensen, S. S., Kaasgaard, T., and Jørgensen, K. (2005) Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr. Drug Delivery 2, 353-362.
22. Sarkar, N. R., Rosendahl, T., Krueger, A. B., Banerjee, A. L., Benton, K. A., Mallik, S., and Srivastava, D. K. (2005) "Uncorking" of liposomes by matrix metalloproteinase-9. J. Chem. Soc.: Chem. Commun. 999-1001.
23. Lauer-Fields, J. L., Sritharan, T., Stack, M. S., Nagase, H., and Fields, G. B. (2003) Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J. Biol. Chem. 278, 18140-18145.
24. Gore, T., Dori, Y., Talmon, Y., Tirrell, M., and Bianco-Peled, H. (2001) Self-assembly of model collagen amphiphiles. Langmuir 17, 5352-5260.
25. Barth, D., Kyrieleis, O., Frank, S., Renner, C., and Moroder, L. (2003) The role of cystine knots in collagen folding and stability, part II. Conformational properties of (Pro-Hyp-Gly)n model trimers with N- and C-terminal collagen type III cystine knots. Chem. - Eur. J. 9, 3703-3714.
26. Koide, T., Yuguchi, M., Kawakita, M., and Kono H. (2002) Metal assisted stabilization and probing of collagenous triple helices, J. Am. Chem. Soc. 124, 9388-9389.
27. Minod, D., Lauer-Fields, J. L., Nagase, H., and Fields, G. B. (2004) Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability. Biochemistry 43, 11474-11481.
28. Lauer-Fields, J. L., Broder, T., Sritharan, T., Chung, L., Nagase, H., and Fields, G. B. (2001) Kinetic analysis of MMP activity using fluorogenic triple-helical substrates. Biochemistry 40, 5795-5803.
29. Lauer-Fields, J. L., and Fields, G. B. (2002) Triple helical peptide analysis of collagenolytic protease activity. Biol. Chem. 383, 1095-1105.
30. Fiori, S., Sacca, B., and Moroder, L. (2002) Structural properties of collagenenous heterotrimer that mimics the collagenase cleavage site of collagen type I. J. Biol. Chem. 319, 1235-1242.
31. Minond, D., Lauer-Fields, J. L., Cudic, M., Overall, C. M., Pei, D., Brew, K., Moss, M. L., and Fields, G. B. (2007) Differentiation of secreted and membrane-type metrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences. Biochemistry 46, 3724-3733.
32. Rezler, E. M., Khan, D. R., Lauer-Fields, J., Cudic, M., Baronas-Lowell, D., and Fields, G. B. (2007) Targeted drug delivery utilizing protein-like molecular architecture. J. Am. Chem. Soc. 129, 4961-4972.
33. Pokorny, A., Birkbeck, T. H., and Almeida, P. F. F. (2002) Mechanism and kinetics of δ-lysin interaction with phospholipid vesicles. Biochemistry 41, 11044-11056.
34. Kakinoki, S., Hirano, Y., and Oka, M. (2005) On the stability of polyproline-I and II structures of proline oligopeptides. Polym. Bull. 53, 109-115.
35. Potma, E. O., and Xie, X. S. (2005) Direct visualization of lipid phase segregation in single lipid bilayers with coherent anti-stokes Raman scattering microscopy. ChemPhysChem 6, 77-79.